AIM IMMUNOTECH INC (AIM)
US00901B1052 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -28.96M | -19.45M | -19.13M | -14.40M | -9.53M | |||
| Depreciation Amortization | 238.00K | 256.00K | 775.00K | 733.00K | 792.00K | |||
| Change In Working Capital | 7.13M | 966.00K | 895.00K | 605.00K | -543.00K | |||
| Interest Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | 326.00K | 2.12M | 3.49M | 2.69M | 217.00K | |||
| OPERATING CASH FLOW | -21.27M | -16.11M | -13.96M | -10.37M | -9.07M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -585.00K | -271.00K | -633.00K | -595.00K | -365.00K | |||
| Other Investing Activity | -247.00K | 11.26M | 2.00K | -8.57M | -5.78M | |||
| INVESTING CASH FLOW | -832.00K | 10.99M | -631.00K | -9.16M | -6.15M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | -4.85M | -4.68M | 1.08M | |||
| Stock Issued/Repurchased | 485.00K | 80.00K | 13.04M | 61.25M | 15.30M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | 0.00 | |||
| FINANCING CASH FLOW | 485.00K | 80.00K | 8.19M | 56.56M | 16.39M | |||
| CHANGE IN CASH | -21.61M | -5.04M | -6.41M | 37.03M | 1.17M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -21.27M | -16.11M | -13.96M | -10.37M | -9.07M | |||
| Capital Expenditure | -585.00K | -271.00K | -633.00K | -595.00K | -365.00K | |||
| FREE CASH FLOW | -21.85M | -16.38M | -14.60M | -10.96M | -9.43M | |||
All data in USD